📖Women undergoing #intravascular brachytherapy for #ISR had higher rates of target lesion revascularization, #MI & MACE vs men despite similar procedures. Highlights need for sex-specific strategies💡 ➡️ https://t.co/MLE1m4xrTg @KrityaMangesh @KharsaChloe @AlpeshShahMD

Houston IC fellowship case competition quarterly series was amazing. Great faculty, physicians and fellows. 100 in attendance. Inspiring IC imaging work from six cardiology programs presented by a fellow, and the winner is hanad Bashir. @HMHCardioFellow @SLittleMD @WilliamZoghbi

🩺 Excited to share our study in @IJCardio: The MADISON Score — a simple clinical tool to predict significant left main or 3-vessel disease in NSTE-ACS. It also carries prognostic value for in-hospital outcomes like cardiogenic shock and MACE. 📄 https://t.co/JJABicFLET

TCT 2025 Day 2: Presented 2 abstracts 👉🏽 Sex-based differences post IV brachytherapy for ISR ❗️High TLR in women 👉🏽 Procedural success rate in CTO PCI in small versus large vessels ❗️Low procedural success rates in small vessels @AlpeshShahMD @KharsaChloe #MedTwitter #TCT2025

Learning IVUS at the engagement hub with the Master 👏 🙏! @AlpeshShahMD #TCT2025 @TCTConference @TCTMD @crfheart

The obesity paradox in CTO PCI🫀 In 503 CTO PCI cases: Obese patients had: ⚠️Lower procedural success ⚠️Higher radiation exposure ✅Similar long-term outcomes 💡BMI alone should not rule out CTO PCI! 🔗: https://t.co/K5B0SJt3WN @AlpeshShahMD @KrityaMangesh

Join us for this informative lecture where Alpesh Shah, MD will share how he uses coronary IVUS to guide stent implantation and post stent optimization #TCT2025 https://t.co/kHoYj9YofJ

Please register and join us at our quarterly Houston fellowship case competition series. This series highlights amazing cases done and presented by our fellows representing all six top fellowship programs. Great opportunity to share and learn.

Privileged to work with this amazing ❤️team @HMethodistCV @ACCinTouch @ASE360 @SCMR @Heart_SCCT @escardio @SCAI

Addressing the Non Culprit in STEMI With Dr. Alpesh Shah “Evidence that PCI of non-culprit lesions leads to better outcomes” “predominantly driven by a lower rate of recurrent ischemia and recurrent MI” @AlpeshShahMD @Dallas_PCI #dallaspci2025 @Obadah1Md

A must watch for every cardiologist! Extremely nuanced and clinically relevant @WilliamZoghbi

🔴New Publication🔴 🫀Does CKD affect brachytherapy outcomes in ISR? ☢️ 227 pts (54 CKD) 1-yr MACE: 63% (CKD) vs 33% 🎯 TLR: 31.5% vs 18% 🩸 Bleeding: CKD only (5.6%) ♂️ Within CKD: male sex ↓ TLR (HR 0.15) Full text link below👇 @AlpeshShahMD @AndrewFarach @HMethodistCV

Dialysis remains an Achilles heel in CAD PCI world. Outcomes remain challenging whether a patient is young or old. Great work by @Taha_Hatab1

Congratulations @KharsaChloe . No need to worry about overlap margins or double dwell in brachytherapy IVBT for treatment of coronary ISR during PCI. Excellent paper from houston Methodist registry. @HMethodistCV @AndrewFarach

IVUS reduces mortality & major CV events by assessing plaque morphology, vessel sizing & stent placement. IVUS Imaging-Guided Percutaneous Coronary Intervention: Evidence & Implications - @safinmc Neal Kleiman @alpeshshahMD #DeBakeyCVJournal https://t.co/cgkEdTBkUw @NadeenFaza

This #SEE IVUS technique is a game changer for precise, fast and detailed method to optimize IVUS guided PCI using eagle eye Philips IVUS. Everyone will feel more empowered to perform IVUS consistently.

Amazing job @KharsaChloe . Accurate and granular data from @HMethodistCV a single center experience over 5 years. Thank you to the entire team of post docs, fellows and Co authors in putting together a Herculean effort.

Congratulations to authors. A must read!

Excited to host Houston intravascular imaging course focusing on precision PCI techniques and IVUS integration for optimizing outcomes. Available for all levels of learners committed to PCI excellence

Yet another trial in STEMI with multivessel disease: in OPTION-STEMI, immediate complete revascularization was not shown to be non-inferior to staged complete revascularization during the index admission, looking at death, non-fatal MI, or unplanned revascularization at 1 year.